ALHC
Alignment Healthcare, Inc. · Healthcare · Medical - Healthcare Plans
Momentum inputs (comparable managers):
holder breadth +11.1% ·
share flow -11.7% ·
net new positions +10.0%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 104 | -4 | 153.25M | $3.65B | +8 | −12 |
| Q1 2026 | 111 | +15 | 140.61M | $2.43B | +19 | −5 |
| Q4 2025 | 96 | +1 | 127.62M | $2.52B | +2 | n/a |
| Q3 2025 | 20 | +1 | 84.25M | $1.47B | +1 | −1 |
| Q2 2025 | 17 | 0 | 71.35M | $998.91M | +1 | −1 |
| Q1 2025 | 14 | 0 | 21.82M | $406.29M | +2 | −2 |
| Q4 2024 | 14 | +3 | 25.36M | $285.33M | +3 | n/a |
| Q3 2024 | 10 | +1 | 10.84M | $128.16M | +2 | −1 |
| Q2 2024 | 9 | n/a | 12.27M | $95.98M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.18M | -7.2% | $49.42M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 2 | Geode Capital Management ✦ (passive) | 2.44M | +1.4% | $28.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Renaissance Technologies ✦ | 1.53M | -2.0% | $18.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.31M | +2403.5% | $15.50M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 492.29K | -71.4% | $5.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 336.08K | +73.8% | $3.97M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 7 | Norges Bank ✦ (passive) | 332.83K | -22.8% | $3.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 118.70K | New | $1.40M | 0.0% | New | 1 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 63.16K | New | $746,587 | 0.0% | New | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 30.00K | -78.6% | $354,600 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $1.40M | 0.0% |
| Arrowstreet Capital | $746,587 | 0.0% |
Exited
| Citadel Advisors | $9.83M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 290 holders, 201.46M shares, $3.20B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 32.48K sh · $269,576
Officer, Director · 23.51K sh · $202,430
Officer, Director · 27.40K sh · $356,200
Officer · 122.71K sh · $1.56M
Officer, Director · 385.27K sh · $4.89M
Officer, Director · 172.60K sh · $2.24M
Officer · 5.00K sh · $70,000
Officer, Director · 298.00K sh · $4.14M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology